Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN99796543) titled 'Deferred registration - AstraZeneca/United Kingdom Code: D7260C00014' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.
Purpose: Treatment
Primary Sponsor: AstraZeneca (Sweden)
Condition:
The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.
Other
Intervention:
The Health Resear...